| Code | Description | Claims | Beneficiaries | Total Paid |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
577 |
551 |
$142K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
332 |
259 |
$62K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,135 |
1,046 |
$55K |
| 36415 |
Collection of venous blood by venipuncture |
3,143 |
2,676 |
$50K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
839 |
713 |
$31K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
191 |
168 |
$28K |
| 71046 |
Radiologic examination, chest; 2 views |
320 |
247 |
$28K |
| 80053 |
Comprehensive metabolic panel |
378 |
327 |
$27K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
52 |
50 |
$21K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
370 |
357 |
$20K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
569 |
501 |
$15K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
27 |
25 |
$11K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
65 |
55 |
$10K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
616 |
591 |
$8K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
53 |
51 |
$7K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
29 |
26 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
84 |
83 |
$3K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
107 |
93 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
58 |
56 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
58 |
56 |
$2K |
| 86140 |
|
87 |
77 |
$2K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13 |
12 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
30 |
28 |
$1K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
93 |
79 |
$1K |
| 86769 |
|
14 |
14 |
$1K |
| 87081 |
|
26 |
26 |
$934.91 |
| 71045 |
Radiologic examination, chest; single view |
25 |
12 |
$882.09 |
| 83655 |
|
13 |
13 |
$759.64 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
15 |
13 |
$464.85 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
13 |
13 |
$377.85 |